Literature DB >> 10638696

Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation.

T W Chow1, J D Hellums, P Thiagarajan.   

Abstract

Shear-induced activation of platelets plays a major role in vascular thrombosis. Shear stress tends to increase both platelet aggregation and procoagulant activity. One mechanism for increased procoagulant activity is promotion of the transbilayer movement of anionic phospholipids from the inner to the outer leaflet of the platelet membrane bilayer. This is accompanied by vesiculation of the platelet membrane, resulting in the formation of procoagulant membrane particles called microvesicles. In this study we have examined the effect of various platelet agonists on shear-induced platelet microvesiculation and the development of platelet procoagulant activity. Normal citrated whole blood was subjected to laminar shear rate up to 12,500 sec(-1) (shear stress approximately 375 dyne/cm2) in a cone-and-plate viscometer, and the formation of platelet microvesicles was measured by flow cytometry under different conditions. Elevated levels of shear stress induced significant microvesiculation. We investigated the effects of adenosine diphosphate, epinephrine, thromboxane A2 analog, collagen, and thrombin receptor activation peptide (SFLLRN) on shear-induced platelet microvesiculation. The thrombin peptide significantly increased shear-induced microvesicle formation. In contrast, under similar conditions, the other agonists had no significant effect on shear-induced microvesiculation. These studies suggest that thrombin formed in the vicinity of primary hemostatic plugs in areas of elevated shear stress may have a major role in the propagation of thrombi by potentiating shear-induced platelet microvesiculation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638696     DOI: 10.1016/s0022-2143(00)70022-9

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

Review 1.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 2.  Clinical relevance of microparticles from platelets and megakaryocytes.

Authors:  Joseph E Italiano; Albert T A Mairuhu; Robert Flaumenhaft
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 3.  Traumatic brain injury-associated coagulopathy.

Authors:  Jianning Zhang; Rongcai Jiang; Li Liu; Timothy Watkins; Fangyi Zhang; Jing-fei Dong
Journal:  J Neurotrauma       Date:  2012-10-31       Impact factor: 5.269

Review 4.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

5.  Platelet function tests: why they fail to guide personalized antithrombotic medication.

Authors:  Diana A Gorog; Young-Hoon Jeong
Journal:  J Am Heart Assoc       Date:  2015-05-26       Impact factor: 5.501

Review 6.  The Role of Platelet-Derived Extracellular Vesicles in Immune-Mediated Thrombosis.

Authors:  Alicia S Eustes; Sanjana Dayal
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.